ECR 2019

X1, Booth AI-17

Feb 27 - March 03

Austria Center Vienna

Precise. Powerful. Proven.

Breast Health Solutions

Book a Meeting

Learn More

At this year’s European Society of Radiology (ECR), explore our suite of Breast Health Solutions for advanced cancer detection built on artificial intelligence. Discover how our solutions can best address the challenges faced by your healthcare facility, and most importantly, deliver quality care to your patients.

We will be showcasing ProFound AI™ for DBT, a high-performing, concurrent-read, cancer detection and workflow solution that rapidly analyzes each image accurately, detecting both malignant soft tissue densities and calcifications with unrivaled accuracy. We will also preview ProFound AI for 2D mammography* built on deep learning technology.

We are transforming breast cancer detection. Learn how at X1, booth AI-17 and experience our groundbreaking technology live on the show floor.

* CE Mark Pending, Not FDA Approved

Friday, March 1st, 18:00 CET

DO & CO Hotel Vienna

Food and cocktails will be served

Advanced RSVP required

Space is limited, register today!



Arrive by 18:00 CET for a chance to win an Apple Watch

New Frontier: Predicting Breast Cancer through Artificial Intelligence

Join your peers for an evening reception in beautiful downtown Vienna for cocktails, food and networking with leaders focused on transforming breast cancer detection.

They will share their personal experience with ProFound AI in research and clinical practice and their vision for risk assessment.


Risk stratified approach to breast cancer screening

Per Hall, MD

Professor/Senior Physician
Karolinska Institutet

ProFound AI Experience: 500 consecutive screen detected abnormalities

Sylvia H. Heywang-Köbrunner, MD
Head of Reference Center Mammography Munich, Head of Brustdiagnostik Munich, Head of FFB gGmbH

Experience with Profound AI in private practice

Axel Gräwingholt, MD

Radiologie am Theater

Learn More at Clinical Presentations & Exhibits

Case Examples to Demonstrate Positive and Negative Impacts of a Deep Learning Based Concurrent Artificial Intelligence System for Digital Breast Tomosynthesis

Thursday, February 28th | 12:00 - 13:00 CET

Voice of EPOS Stage 4

Jeff Hoffmeister, MD
Vice President and Medical Director at iCAD, Inc.

How AI Can Improve Diagnostic Performance and Reduce Reading Time in Breast Tomosynthesis: Presented by iCAD, Inc.

Friday, March 1st | 13:50 CET

Artificial Intelligence Theatre

Senthil Periaswamy, PhD
Vice President of Research, iCAD Inc.

Learn More>

Register for a meeting or demonstration

See you in Vienna!


© 2018, iCAD Inc.  All rights reserved.  iCAD, the iCAD logo,, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.

ECR 2019

X1, Booth AI-17, Feb 27 - March 03

Austria Center Vienna